Impact of early changes in serum biomarkers following androgen deprivation therapy on clinical outcomes in metastatic hormone-sensitive prostate cancer

BACKGROUND: Less evidence is known about the role of early changes in serum biomarker after androgen deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). Here we evaluated the impact of pre-treatment prognostic factors and early changes in serum biomarkers...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Urol
Main Authors: Sato, Hiromi, Narita, Shintaro, Tsuchiya, Norihiko, Koizumi, Atsushi, Nara, Taketoshi, Kanda, Sohei, Numakura, Kazuyuki, Tsuruta, Hiroshi, Maeno, Atsushi, Saito, Mitsuru, Inoue, Takamitsu, Satoh, Shigeru, Nomura, Kyoko, Habuchi, Tomonori
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5941329/
https://ncbi.nlm.nih.gov/pubmed/29739368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-018-0353-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados